• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

来自混合白膜层的随机供体血小板浓缩物的体内评估。

In-vivo evaluation of random donor platelet concentrates from pooled buffy coats.

作者信息

Klüter H, Dörges L, Maass E, Wagner T, Bartels H, Kirchner H

机构信息

Institute of Immunology and Transfusion Medicine, University of Lübeck School of Medicine, Germany.

出版信息

Ann Hematol. 1996 Aug;73(2):85-9. doi: 10.1007/s002770050206.

DOI:10.1007/s002770050206
PMID:8774617
Abstract

Random-donor platelet concentrates (PC) prepared from pooled buffy coats have recently been described as an alternative method for platelet preparation. We evaluated such PCs in the clinical setting compared with a standard PC from platelet apheresis. PCs were prepared either from pools of buffy coats (BC-PC) or from single donors (SD-PC) with the cell separator CS-3000 plus. PCs were stored for up to 5 days before transfusion. We compared fresh PC (day 1) with stored (day 2-3) and long-stored PC (day 4-5). For analysis, platelet increment in the recipient was determined immediately and 16-22 h (mean 20 h) after transfusion, corrected for total body area and transfused platelets (CCI). A total of 316 PCs were administered to 36 thrombocytopenic patients suffering from various hematological disorders. Patients with detectable HLA or platelet-specific antibodies or splenomegaly were excluded from the study. Mean platelet content of the PC was 262 x 10(9) for BC-PC and 251 x 10(9) for SD-PC. The 20-h CCI after transfusion of fresh PC was slightly higher with BC-PC than with SD-PC (14.5 versus 11.9; p = 0.19), but values did not differ significantly between the two types of PC on any day of storage. For BC-PC, 20-h CCI decreased with further storage by 30% (10.2; p = 0.02). For SD-PC a decrease by 9% was not significant. In conclusion, platelet concentrates prepared from pools of buffy coats showed excellent transfusion results when administered fresh, but storage decreased the CCI by 30%. No significant difference from PCs from plateletpheresis was observed on any day of storage. Both types of platelet concentrates were capable of sufficient platelet increment even when stored for up to 5 days.

摘要

近期,由混合白膜层制备的随机供者血小板浓缩物(PC)被描述为一种血小板制备的替代方法。我们在临床环境中对这类PC与单采血小板制备的标准PC进行了评估。PC由白膜层池(BC-PC)或使用CS-3000 plus细胞分离仪从单采供者(SD-PC)制备。PC在输血前储存长达5天。我们比较了新鲜PC(第1天)与储存PC(第2 - 3天)以及长期储存PC(第4 - 5天)。为进行分析,在输血后立即以及输血后16 - 22小时(平均为20小时)测定受者的血小板增加值,并根据体表面积和输注的血小板进行校正(校正计数增量,CCI)。总共向36名患有各种血液系统疾病的血小板减少患者输注了316份PC。有可检测到的HLA或血小板特异性抗体或脾肿大的患者被排除在研究之外。BC-PC的PC平均血小板含量为262×10⁹,SD-PC为251×10⁹。新鲜PC输血后20小时的CCI,BC-PC略高于SD-PC(14.5对11.9;p = 0.19),但在储存的任何一天,两种类型的PC之间的值均无显著差异。对于BC-PC,随着进一步储存,20小时CCI下降了30%(10.2;p = 0.02)。对于SD-PC,下降9%不显著。总之,由白膜层池制备的血小板浓缩物新鲜输注时显示出优异的输血效果,但储存会使CCI降低30%。在储存的任何一天,均未观察到与单采血小板制备的PC有显著差异。即使储存长达5天,两种类型的血小板浓缩物都能够实现足够的血小板增加值。

相似文献

1
In-vivo evaluation of random donor platelet concentrates from pooled buffy coats.来自混合白膜层的随机供体血小板浓缩物的体内评估。
Ann Hematol. 1996 Aug;73(2):85-9. doi: 10.1007/s002770050206.
2
Evaluation of platelet function using the in vitro bleeding time and corrected count increment of transfused platelets. Comparison between platelet concentrates derived from pooled buffy coates and apheresis.使用体外出血时间和输注血小板校正计数增加值评估血小板功能。比较来自混合白膜层和单采血小板的浓缩血小板。
Vox Sang. 1996;70(2):69-75. doi: 10.1111/j.1423-0410.1996.tb01296.x.
3
Transfusion of platelet concentrates--clinical evaluation of two preparations.浓缩血小板输注——两种制剂的临床评估
Eur J Haematol. 1996 Oct;57(4):307-11. doi: 10.1111/j.1600-0609.1996.tb01382.x.
4
Determination viability of a transfused platelet product by corrected count increment and percentage platelet response.通过校正计数增加值和血小板反应百分比来确定输注血小板产品的活力。
Pan Afr Med J. 2017 Jul 28;27:226. doi: 10.11604/pamj.2017.27.226.12116. eCollection 2017.
5
Platelet concentrates in an additive solution prepared from pooled buffy coats. In vivo studies.由混合的白膜层制备的添加溶液中的血小板浓缩物。体内研究。
Vox Sang. 1993;64(3):133-8. doi: 10.1111/j.1423-0410.1993.tb05150.x.
6
Transfusion of platelet concentrates from pooled buffy-coats: comparison of bedside vs. prestorage leukofiltration.来自混合白膜层的浓缩血小板输注:床边白细胞过滤与储存前白细胞过滤的比较
Transfus Med. 2000 Mar;10(1):59-65. doi: 10.1046/j.1365-3148.2000.00232.x.
7
Clinical effect of buffy-coat vs. apheresis platelet concentrates in patients with severe thrombocytopenia after intensive chemotherapy.浓缩红细胞与单采血小板浓缩物对强化化疗后严重血小板减少症患者的临床疗效比较
Vox Sang. 2007 Jul;93(1):42-8. doi: 10.1111/j.1423-0410.2007.00917.x.
8
Relationship of the time of storage and transfusion reactions to platelet concentrates from buffy coats.
Transfusion. 1997 May;37(5):528-30. doi: 10.1046/j.1537-2995.1997.37597293886.x.
9
Evaluation of platelet concentrates prepared from buffy coats and stored in a glucose-free crystalloid medium.评估由白膜层制备并储存在无葡萄糖晶体培养基中的血小板浓缩物。
Transfusion. 1989 Sep;29(7):605-9. doi: 10.1046/j.1537-2995.1989.29789369678.x.
10
Storage-induced change in platelet transfusion response evaluated by serial transfusions from one donor to one patient.通过从一名供体到一名患者的连续输血评估储存引起的血小板输血反应变化。
Transfusion. 2019 Feb;59(2):723-728. doi: 10.1111/trf.15079. Epub 2018 Dec 12.

引用本文的文献

1
Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.比较不同血小板计数阈值,以指导预防性血小板输注的应用,从而预防血液系统疾病患者在骨髓抑制性化疗或干细胞移植后发生出血。
Cochrane Database Syst Rev. 2015 Nov 18;2015(11):CD010983. doi: 10.1002/14651858.CD010983.pub2.
2
Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.不同剂量预防性血小板输注对预防血液系统疾病患者在骨髓抑制性化疗或干细胞移植后出血的作用
Cochrane Database Syst Rev. 2015 Oct 27;2015(10):CD010984. doi: 10.1002/14651858.CD010984.pub2.
3
Efficacy and Adverse Events of Platelet Transfusion Product-Specific Differences.血小板输注制品的疗效及不良事件——产品特异性差异
Transfus Med Hemother. 2008;35(2):102-105. doi: 10.1159/000119117. Epub 2008 Mar 17.
4
[Conventional vs pathogen-inactivated platelet concentrates for the treatment of perioperative coagulopathy. A prospective cohort study].[传统血小板浓缩物与病原体灭活血小板浓缩物治疗围手术期凝血病的前瞻性队列研究]
Chirurg. 2011 Apr;82(4):348-58. doi: 10.1007/s00104-010-2023-2.
5
2 Platelet Concentrates.2 血小板浓缩物。
Transfus Med Hemother. 2009;36(6):372-382.